'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option

Psycho-Oncology

Volumn 23, Issue 12, 2014, Pages 1391-1398

  O'Callaghan, Clare ^a,b,c,d   Dryden, Tracey ^b,e   Hyatt, Amelia ^b   Brooker, Joanne ^d,f   Burney, Sue ^d,f   Wootten, Addie C ^g   White, Alan ^h   Frydenberg, Mark ^f   Murphy, Declan ^b,i   Williams, Scott ^b,c   Schofield, Penelope ^b,c,j  

^a ST VINCENT S HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CABRINI INSTITUTE   (Australia)

^e Leukaemia Foundation   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g ROYAL MELBOURNE HOSPITAL   (Australia)

^h Prostate Cancer Foundation   (Australia)

ⁱ EPWORTH HEALTHCARE   (Australia)

^j THE UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Active surveillance; Cancer; Oncology; Prostate cancer; Qualitative research

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; ARTICLE; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DESCRIPTIVE RESEARCH; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MALE; MEDICAL DECISION MAKING; PROSTATE CANCER; PROSTATECTOMY; QUALITATIVE RESEARCH; TREATMENT DECISION MAKING;

EID: 84916214258     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3576     Document Type: Article

References (40)

1. Collin SM, Martin RM, Metcalfe C, et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 2008;9:445-452. DOI: 10.1016/S1470-2045(08)70104-9
2. Thompson IM, Klotz L.Active surveillance for prostate cancer. JAMA 2010; 304:2411-2412. DOI: 10.1001/jama.2010.1761
3. Albertsen PC. What is the risk posed by prostate cancer? J Natl Cancer Inst Monogr 2012;45:169-174. DOI: 10.1093/jncimonographs/lgs028
4. Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol 2004;5:101-106.
5. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557-566.
6. van den Bergh RC, Korfage IJ, Bangma CH. Psychological aspects of active surveillance. Curr Opin Urol 2012;22:237-242. DOI: 10.1097/MOU.0b013e328351dcb1
7. Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011;29:3669-3676. DOI: 10.1200/JCO.2011.34.9738
8. Dall'Era MA, Kane CJ. Watchful waiting versus active surveillance: appropriate patient selection. Curr Urol Rep 2008;9:211-216.
9. Urological Society of Australia and New Zealand PSA Testing Policy 2009 Executive Summary. [Internet] Available from: http://www.usanz.org.au/uploads/29168/ufiles/USANZ-2009-PSA-Testing-Policy-Final1.pdf, accessed on 11/02/2014
10. National Comprehensive Cancer Network Clinical PracticeGuidelines inOncology. Prostate cancer. Version 3.2012 [Internet] Available from: http://www.tri-kobe.org/nccn/guideline/urological/english/prostate.pdf, accessed on 27/03/2014
11. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Prostate cancer. Version 1.2014 [Internet] Available from: http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf, accessed on 27/03/2014
12. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203-213. DOI: 10.1056/NEJMoa1113162
13. Degroot JM, Brundage MD, Lam M, et al. Prostate cancer-specific survival differences in patients treated by radical prostectomy versus curative radiotherapy. Can Urol Assoc J 2013;7(5-6):e299-e305. DOI: 10.5489/cuaj.11294
14. NIH State-of-the-Science Conference Statement: role of active surveillance in the management of men with localized prostate cancer. Final Panel Statement, 2011. [Internet] Available from: http://consensus.nih.gov/2011/prostatefinalstatement.htm, accessed on 11/02/2014
15. th August, 2012: Almost half of Australian men diagnosed with low risk prostate cancer avoid surgery. [Internet] Available from: http://www.usanz.org.au/uploads/29168/ufiles/120810-Low-risk-men-avoid-surgery.pdf, accessed on 11/02/2014
16. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 2011;77:588-591. DOI: 10.1016/j.urology.2010.10.039
17. Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL. Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc 2011;103:468-478.
18. Robles LA, Chou S, Cole OJ, Hamid A, Griffiths A, Vedhara K. Psychological and social factors infl uencing patients' treatment selection for localised prostate cancer. In Advances in prostate cancer, Hamilton G (ed.). 2013. [Internet] Available from: http://www.intechopen.com/books/advances-in-prostate- cancer/psychological-and-social-factors-influencing-patients-treatment-selection-for-localised-prostate-can, accessed on 05/06/ 2013. DOI: 10.5772/52641
19. Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Counsel 2012; 87:369-374. DOI: 10.1016/j.pec.2011.11.009
20. van den Bergh RC, van Vugt HA, Korfage IJ, et al. Disease insight and treatment perception of men on active surveillance for early prostate cancer. BJU Int 2010;105:322-328. DOI: 10.1111/j.1464-410X.2009.08764.x
21. Seiler D, Randazzo M, Leupold U, et al. Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners. Urology 2012;80:564-569. DOI: 10.1016/j.urology.2012.04.053
22. Davison BJ, Oliffe JL, Pickles T, Mróz L. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 2009;36:89-96.
23. Steginga SK, Turner E,Donovan J. The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research. World J Urol 2008:26;469-474. DOI: 10.1007/s00345-008-0279-7
24. Oliffe JL, Davison BJ, Pickles T, Mróz L. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res 2009;19:432-443. DOI: 10.1177/1049732309332692
25. Sinfield P, Baker R, Agarwal S, Tarrant C. Patient-centred care: what are the experiences of prostate cancer patients and their partners? Patient Educ Couns 2008;73:91-96. DOI: 10.1016/j.pec.2008.05.001
26. Sandelowski M Whatever happened to qualitative description? Res Nurs Health 2000;23(4):334-340.
27. Corbin J, Strauss A. Basics of Qualitative Research 3e: Techniques and Procedures for Developing Grounded Theory. Sage: Thousand Oaks, California, 2008.
28. Rice P, Ezzy D. Qualitative Research Methods: A Health Focus. Oxford University Press: Oxford, 1999.
29. Muhr T. ATLAS/ti: the knowledge workbench [CD-ROM]. Version 7.0: ATLAS.ti Scientific Software Development, GmbH, Berlin. 2012.
30. Kitto S, Chesters J, Grbich C. Quality in qualitative research: criteria for authors and assessors in the submission and assessment of qualitative research articles for the Medical Journal of Australia. Med J Aust 2008;188(4):243-246.
31. Segaran S, Jelski J, Burns-Cox N. Active surveillance: a cautionary tale. J Clin Urol 2013. DOI: 10.1177/2051415813496412
32. Kirby R. The flaws of the PIVOT study of radical prostatectomy versus observation; don't give up on PSA just yet. BJU Int 2013. [Internet] Available from: http://www.bjuinternational.com/bjui-blog/the-flaws-of-the- pivot-study-of-radical-prostatectomy-versus-observation-dont-give-up-on-psa-just-yet/, accessed on 06/02/2014.
33. Hoffman RM. Improving the communication of benefits and harms of treatment strategies: decision aids for localized prostate cancer treatment decisions. J Natl Cancer Inst Monogr 2012(45):197-201. DOI: 10.1093/jncimonographs/lgs023
34. Feldman-Stewart D, Brundage MD, Van Manen L, Svenson O. Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect 2004;7:126-141.
35. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer 2006;106:1865-1874.
36. Svenson O. Differentiation and consolidation theory of human decision making: a frame of reference for the study of pre and post-decision processes. Acta Psychol (Amst) 1992;80:143-168.
37. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med, 1997;44:681-692.
38. Candib L. Truth telling and advance planning at the end of life: problems with autonomy in a multicultural world. Fam Sys Health 2002;20:213-228.
39. Bangma CH, Bul M, van der Kwast TH, et al. Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol 2013;85 (3):295-302. DOI: 10.1016/j.critrevonc.2012.07.005
40. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-661.